News that may have an impact on prices of some stocks today

SpiceJet reports highest ever quarterly profit of Rs 319 crore in March quarter

SpiceJet reported its highest-ever quarterly profit at Rs 319 crore in Q4 FY25 . The airline also turned profitable for the full year with Rs 48 crore net profit, its first since FY18. Load factor stood at 88.1% and EBITDA more than doubled. Cost control across the business and lower finance cost led to sharp increase in net profit. Promoters infused Rs 500 crore equity, further boosting financials. It owned a fleet of 22 aircraft and 39 on lease as on March-2025.

HBL Engineering gets new order of Rs 133 crore

South Central Railway has issued letter of acceptance to HBL for provision of the Kavach in Vijayawada — Ballarshah section. The total order value stood at Rs 133 crore (incl. GST). It is to be executed in the 18 months. Company received another order worth Rs 30.7 crore from South Central Railway. Company has order book of Rs 4029 crore as on date.

Sygene International’s Bengaluru facility passes USFDA inspection with zero adverse observations

United States Food and Drug Administration (US FDA) conducted a Good Clinical Practices (GCP) compliance inspection of Syngene International Limited’s facility at Semicon Park, Bengaluru, from June 09, 2025, to June 13, 2025. The inspection concluded successfully, with the facility found to be in compliance with the required regulations. The inspection resulted in zero observations and no Form 483 was issued. The inspection has been classified as No Action Indicated (NAI).

Gas blowout from ONGC well still continuing

Gas is flowing uncontrollably for the second day in a row on Friday from a crude well of Oil and Natural Gas Corp. in Assam’s Sivasagar district after a blowout, officials said. While ONGC has begun a detailed probe to find out the reason for the blowout and the process to control the well is progressing.

Maruti, Equitas sign vehicle financing agreement

Maruti Suzuki India Ltd has partnered with private sector Equitas Small Finance Bank to offer vehicle financing options to its customers. A memorandum of understanding between the two entities was signed with an aim to provide retail financing options for new cars, used cars and commercial vehicles.

RBI extends Prashant Kumar’s tenure as Yes Bank CEO

Reserve Bank of India has extended Prashant Kumar’s tenure as Yes Bank CEO. He will continue until a successor is found. The extension is effective from October 6, 2025. Kumar’s leadership began in March 2020.

Care Edge ratings expects banks’ cost of credit to rise in FY 26

Care Edge Ratings anticipates a potential rise in banks’ credit costs in FY26 due to stress in unsecured and microfinance loans. Despite this, strong provision buffers, particularly among PSBs with high Provision Coverage Ratios, position banks to absorb potential losses. While asset quality is expected to slightly deteriorate, it will remain manageable, offset by corporate deleveraging.

ITC completes acquisition of SNBPL for Rs 400 crore

ITC Ltd has completed the acquisition of Sresta Natural Bio-products Private Limited (SNBPL) for Rs 400 crore in an all-cash deal, marking a strategic entry into the fast-growing organic food market. The transaction involves the purchase of 1.87 crore equity shares, making SNBPL a wholly owned subsidiary of ITC. In addition, consideration of up to Rs 72.5 crore payable in the next 24 months. It is engaged in the business of manufacturing and selling organic food products under the ‘24 Mantra Organic’ brand.

Themis Medicare, Gujarat Themis amalgamation called off

With reference to earlier disclosure dated November 18, 2024, wherein the Company had informed about proposed Scheme of Amalgamation of Gujarat Themis Biosyn Limited (“Transferor Company”) with Themis Medicare. Board of Directors of Gujarat Themis Biosyn Limited, at its meeting held on 13th June 2025, after due deliberation and stated reasons has decided not to proceed with the proposed amalgamation and has accordingly approved withdrawal of the scheme of amalgamation.

Rekha Jhunjhunwala sells another 3% stake in Nazara Technologies

Ace investor Rekha Jhunjhunwala continues to pare her stake in Nazara Technologies. On June 13, Jhunjhunwala sold over a 3% stake in the company through bulk deals on both the BSE and NSE. She offloaded 13 lakh shares on the BSE at an average price of Rs 1,225.19 per share, and another 14 lakh shares on the NSE at Rs 1,225.63 apiece.

Birla Corporation declared preferred bidder for limestone block in Jaisalmer

Birla Corporation said it has been declared the preferred bidder for the Gourum Khan Ki Dhani (South) limestone block in Jaisalmer, Rajasthan, following a successful bid in the state’s e-auction process. The government of Rajasthan’s director of mines and geology, through a notification dated June 12, 2025, confirmed the company’s selection for the grant of a mining lease over the block located in Jaisalmer district.

DLF to invest Rs 5,500 crore in luxury housing project in Gurugram

DLF Ltd will invest around Rs 5,500 crore to develop a luxury housing project in Gurugram, as it seeks to achieve record sales bookings this fiscal on high demand. According to sources, the company will soon launch an 18-acre project ‘DLF Privana North’ in Sector 76/77 Gurugram, comprising more than 1,150 apartments. The estimated cost to develop this project is around Rs 5,500 crore, they added. This upcoming project is part of its 116-acre township ‘DLF Privana’.

Dishman Carbogen Amics’ facility in Naroda passes US FDA inspection with zero adverse observations

US FDA inspection planned between 9th June, 2025 to 13th June, 2025 at DCAL’s facility in Naroda, Ahmedabad, was successfully completed on 12th June, 2025. The inspection was concluded without any observation or issuance of form 483’s, confirming that no concerns were discovered during the inspection. Thus, the company’s facilities at Naroda and Bavla in India, and multiple group facilities in Switzerland and Netherlands continue to be approved by the US FDA.

Arkade Developers to do development project in Thane

The company forayed into Maharashtra’s Thane metro area with 6.28-acre project with an estimated gross development value of Rs 2,000 crore. Strategically nestled at Kasarvadavali off Ghodbunder Road in Thane West, this upcoming development is set to emerge as a landmark destination, offering a harmonious mix of thoughtfully crafted 2, 3, and 4 BHK residences along with curated retail and commercial spaces.

Natco Pharma’s API facility in Mekaguda gets one observation in USFDA inspection

US FDA, in its inspection from June 9 to June 13 at the API manufacturing plant in Mekaguda, Hyderabad, concluded with one observation in form-483. The company believes that the observation is procedural in nature.

Lemon Tree signs new hotel property in Itanagar

Lemon Tree Hotels announced its latest signing Lemon Tree Hotel, Itanagar, Arunachal Pradesh. The property shall be managed by Carnation Hotels Private Limited, a wholly-owned subsidiary of Lemon Tree Hotels Limited. Lemon Tree Hotel, Itanagar will feature 70 well-appointed rooms, a restaurant and other amenities. The Donyi Polo Airport, Itanagar is approx. 25 kms away from the property. Naharlagun (Itanagar) Railway Station is approx. 12 kms from the property.

Sun Pharma’s Halol facility gets 8 observations in USFDA inspection

US FDA conducted a Good Manufacturing Practices (GMP) inspection of Sun Pharmaceutical Industries Limited’s Halol facility (Gujarat, India) from 02 June to 13 June 2025. At the conclusion of the inspection, the US FDA issued a Form-483, with 8 observations. As per communication dated December 08, 2022, the Halol facility was placed under Import Alert by US FDA.

Sun Pharmaceutical Industries Limited announced appointment of Kirti Ganorkar as the Managing Director to succeed Dilip Shanghvi, effective September, 2025. Abhay Gandhi – President & CEO, North America, has decided to pursue his interests outside Sun Pharma. Richard (Rick) Ascroft will be joining as CEO – North America, succeeding Abhay Gandhi. Rick is a seasoned biopharmaceutical executive with more than three decades of experience spanning commercial operations, market access, medical affairs, and corporate affairs across the US and global markets. Aalok Shanghvi – Whole-time Director and Chief Operating Officer, has been additionally entrusted with the responsibility for the North America business wherein Rick will report to Aalok.

NTPC begins operations at Unir-3 of North Karanpura project

The company announced the commencement of commercial operations for Unit-3 (660 MW) of its North Karanpura Super Thermal Power Project (3×660 MW), effective from 00:00 hours on June 15, 2025. With this, NTPC’s total standalone commercial capacity has increased to 60,266 MW, while its group capacity has reached 81,368 MW.

Disclaimer : This content is only for informational purpose. It does not make any recommendation to act or invest. To get any error corrected, write to content@hdfcsec.com.

Source: HDFC Securities Prime Research